Rob Warburton

Rob has a Bachelor of Science degree in microbiology and has been involved in both clinical and pharmaceutical microbiology for the past 26 years. For the last 20 years, Rob has worked in pharmaceutical product development at Eli Lilly and Company designing, executing and interpreting microbial challenge studies for both small and large molecule assets. He is currently the supervisor of the Bioproduct Research and Development microbiology lab at Lilly.